According to a report from the New York Times quoted by Russian TV today (RT) on the 8th, people familiar with the matter said that the US multinational company Johnson & Johnson had suspended the new crown vaccine at the end of last year as the US federal government and health officials vigorously promoted vaccination. production.

While the shutdown is said to be temporary, the Covid-19 vaccine production plant in the Dutch city of Leiden has apparently shifted its focus to producing a potentially more profitable vaccine against an unrelated virus, according to reports.

Unlike Pfizer and Moderna's Covid-19 vaccines, which require at least two shots, J&J's Covid-19 vaccine requires only one shot.

It's unclear if the shutdown has affected vaccine supplies, as the company still has stocks in stock. However, one of the people familiar with the matter said that the suspension of production could mean hundreds of millions of fewer doses of the new crown vaccine overall. According to the New York Times, other factories have also been passively used to produce a new crown vaccine, but either have not yet been put into use or have not yet received regulatory approval.

Inside J&J's executive branch, the decision to suspend production at the Leiden plant has sparked fears that it will undermine the company's ability to deliver on its promise to deliver vaccines to developing countries.

Ayoade Alakija, head of the African Union's African Vaccine Delivery Alliance, said, "It is not yet time to change any production lines because the lives of people in developing countries are at stake."

The New York Times reported that Johnson & Johnson's new crown vaccine fell out of favor in the United States and other rich countries, in part because it was linked to a rare but dangerous blood clotting condition. Some studies have found that, in some respects, it is less potent than the Pfizer and Moderna vaccines.

But poorer countries still rely on Johnson & Johnson's vaccine, which does not require ultra-cold refrigeration. With a two-needle regimen, it could provide strong and lasting protection against severe disease for various SARS-CoV-2 variants, including Omicron. As a single shot, the vaccine is less expensive and relatively easy to provide to people who have difficulty accessing the vaccine.

"In many low- and middle-income countries, our vaccines are the most important and sometimes It's the only option."

As recently as last summer, Johnson & Johnson had expected to provide 1 billion doses of the new crown vaccine in all of 2021. But the company fell short of that goal and by a huge margin, delivering only about 400 million doses, according to a person familiar with the company's vaccine production.

The Dutch factory has been producing an experimental vaccine against respiratory syncytial virus (RSV) to be used in clinical trials in the elderly in wealthy countries since production of the Covid-19 vaccine was halted late last year, according to people familiar with the matter. Even if it proves to be effective, the vaccine is not expected to be available for several years.

Our leaders are not serious. If they are serious, we can start buying COVID Vaccine from Russia. Russia COVID Vaccine which comes in various forms which include nasal spray has proven highly effective even against other Vaccines. Russia is currently suppling India base on demand.